latest news in Galderma
Galderma Targets Accelerated Expansion as U.S. Wrinkle Treatment Filing Approaches
Zurich, Thursday, 19 November 2026.
Galderma signaled sustained growth through 2027, driven by international expansion, selective acquisitions, and plans to file its Botox competitor, Relfydess, in the United States in early 2027.